Clinical trial
A Phase IV, Randomised, Double-blind Study Comparing the Local Tolerability of Two Subcutaneous Heparins, Fraxiparine and Clexane, in Healthy Volunteers.
NCT03841396 is registered in ClinicalTrials.gov with Aspen Global Incorporated as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase IV, Randomised, Double-blind Study Comparing the Local Tolerability of Two Subcutaneous Heparins, Fraxiparine and Clexane, in Healthy Volunteers.
- Lead sponsor
- Aspen Global Incorporated
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 2, 2016
- Completion date
- July 15, 2016
- Enrollment
- 15 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.